The hope is to identify new drugs to help treat COVID-19 patients. (Photo: VCG)
Three anti-inflammatory drugs used to treat malaria, some cancers and Crohn's Disease or rheumatoid arthritis are to be part of a clinical trial for potential treatments for COVID-19 patients, the World Health Organization (WHO) has announced.
The drugs – artesunate, imatinib and infliximab – were selected by an independent expert panel for the Solidarity Plus trial because of their potential in reducing the risk of death in hospitalized COVID-19 patients, the WHO said.
